The MFDS announced on the 8th that Moderna Korea has applied for permission to manufacture and sell the COVID-19 vaccine SPIKEVAX produced by Samsung Biologics in Korea.

The vaccine induces an immune response by injecting antigen genes from COVID-19 in the form of mRNA to produce antigen proteins in the body. The MFDS announced that it will closely review the submitted quality, non-clinical, and clinical data and check the safety and effectiveness of the product to decide whether to approve it.

An official from the MFDS emphasized, "We will continue to do our best to quickly supply safe and effective vaccines to the Korean people."

Meanwhile, the COVID-19 vaccine developed